Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus.

Zhu XW, Deng FY, Lei SF.

Prim Care Diabetes. 2015 Feb;9(1):60-7. doi: 10.1016/j.pcd.2014.03.007. Epub 2014 May 5. Review.

PMID:
24810146
2.

[Atherogenic index of plasma is associated with carotid intima-media thickness in patients with type 2 diabetes mellitus].

Hu YM, Tian HM, Liu R, Chen X.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Sep;35(5):696-8, 707. Chinese.

PMID:
15460423
3.

The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.

Toth PP, Simko RJ, Palli SR, Koselleck D, Quimbo RA, Cziraky MJ.

Cardiovasc Diabetol. 2012 Sep 14;11:109. doi: 10.1186/1475-2840-11-109.

4.

Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women.

Hadaegh F, Hatami M, Tohidi M, Sarbakhsh P, Saadat N, Azizi F.

Lipids Health Dis. 2010 Aug 17;9:85. doi: 10.1186/1476-511X-9-85.

5.

Pattern and predictors of dyslipidemia in patients with type 2 diabetes mellitus.

Karim MN, Ahmed KR, Bukht MS, Akter J, Chowdhury HA, Hossain S, Anwar N, Selim S, Chowdhury SH, Hossain F, Ali L.

Diabetes Metab Syndr. 2013 Apr-Jun;7(2):95-100. doi: 10.1016/j.dsx.2013.02.011. Epub 2013 Mar 27.

PMID:
23680249
6.

Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis.

Amor AJ, Catalan M, Pérez A, Herreras Z, Pinyol M, Sala-Vila A, Cofán M, Gilabert R, Ros E, Ortega E.

Atherosclerosis. 2016 Apr;247:161-9. doi: 10.1016/j.atherosclerosis.2016.02.014. Epub 2016 Feb 17.

PMID:
26921744
7.

Prevalence of dyslipidemia and associated factors in the Yi farmers and migrants of Southwestern China.

Wang B, Wei D, Wang C, Zhang J, Pan L, Ma M, Xue F, Wu Z, Shan G.

Atherosclerosis. 2012 Aug;223(2):512-8. doi: 10.1016/j.atherosclerosis.2012.06.009. Epub 2012 Jun 18.

PMID:
22762728
8.

[Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].

He H, Li Y, Wang C, Tang Y, Yan Z, Lv L, Zhang H, Liu F, Gu Y, Meng T, Guan C, Yu Y, Liu Y.

Wei Sheng Yan Jiu. 2014 Sep;43(5):743-8. Chinese.

PMID:
25438527
9.

Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.

Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M.

Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12.

PMID:
19003544
10.
11.

Non-HDL-cholesterol in an adolescent diabetes population.

Kuryan RE, Jacobson MS, Frank GR.

J Clin Lipidol. 2014 Mar-Apr;8(2):194-8. doi: 10.1016/j.jacl.2013.12.006. Epub 2013 Dec 17.

PMID:
24636179
13.

Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

Chen YH, Du L, Geng XY, Peng YL, Shen JN, Zhang YG, Liu GJ, Sun X.

J Evid Based Med. 2015 Aug;8(3):134-48. doi: 10.1111/jebm.12157.

PMID:
26066789
14.
15.

Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes.

Zoppini G, Targher G, Trombetta M, Lippi G, Muggeo M.

Obesity (Silver Spring). 2009 Feb;17(2):370-4. doi: 10.1038/oby.2008.544. Epub 2008 Dec 4.

16.

Alarming rise in prevalence of atherogenic dyslipidaemia in the black population of Cape Town: the Cardiovascular Risk in Black South Africans (CRIBSA) study.

Peer N, Steyn K, Lombard C, Gaziano T, Levitt N.

Eur J Prev Cardiol. 2014 Dec;21(12):1549-56. doi: 10.1177/2047487313497865. Epub 2013 Jul 23.

PMID:
23881149
17.

Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus.

Pandeya A, Sharma M, Regmi P, Basukala A, Lamsal M.

Nepal Med Coll J. 2012 Dec;14(4):278-82.

PMID:
24579534
18.

Evaluation of the lipid profile in type 2 diabetes mellitus patients in Greece.

Stamouli M, Pouliakis A, Mourtzikou A, Skliris A, Panagiotou I, Mournianakis E, Totos G.

Clin Lab. 2014;60(10):1593-600.

PMID:
25651703
19.

[The change of atherogenic index of plasma (AIP) level in type 2 diabetic pedigrees and the response of AIP to Acarbose or Glimepiride in therapy of type 2 diabetes mellitus].

Yang B, Tian H, Ren Y, Tong N, Yu H, Han L, Ran X.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005 Jun;22(3):560-4. Chinese.

PMID:
16013260
20.

Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.

Akanji AO, Suresh CG, Al-Radwan R, Fatania HR.

Metab Syndr Relat Disord. 2009 Dec;7(6):563-9. doi: 10.1089/met.2009.0034.

PMID:
19642911

Supplemental Content

Support Center